PharmaLogic buys Lantheus plant to build transatlantic radiopharmaceutical CDMO
Less than two years after acquiring the assets, Lantheus is selling its CDMO unit and a New Jersey production plant to PharmaLogic.
Less than two years after acquiring the assets, Lantheus is selling its CDMO unit and a New Jersey production plant to PharmaLogic.
comments(0)
5-min edit window · permanent after that